LPL Financial LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 217 filers reported holding EDITAS MEDICINE INC in Q2 2018. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$619,882
-1.6%
79,472
+3.8%
0.00%
Q2 2023$630,064
+39.1%
76,557
+22.5%
0.00%
Q1 2023$452,915
+4.1%
62,471
+27.4%
0.00%
Q4 2022$435,082
-18.7%
49,051
+12.2%
0.00%
-100.0%
Q3 2022$535,000
+0.9%
43,716
-2.3%
0.00%0.0%
Q2 2022$530,000
-26.5%
44,760
+18.0%
0.00%0.0%
Q1 2022$721,000
-37.7%
37,929
-13.0%
0.00%0.0%
Q4 2021$1,157,000
-46.5%
43,572
-17.2%
0.00%
-50.0%
Q3 2021$2,162,000
-21.8%
52,628
+7.8%
0.00%
-33.3%
Q2 2021$2,766,000
+1.5%
48,834
-24.8%
0.00%0.0%
Q1 2021$2,726,000
-34.9%
64,915
+8.7%
0.00%
-40.0%
Q4 2020$4,186,000
+159.8%
59,710
+4.0%
0.01%
+66.7%
Q3 2020$1,611,000
+3.6%
57,406
+9.2%
0.00%0.0%
Q2 2020$1,555,000
+216.7%
52,562
+112.3%
0.00%
+200.0%
Q1 2020$491,000
-24.6%
24,764
+12.7%
0.00%0.0%
Q4 2019$651,000
+77.4%
21,970
+36.2%
0.00%0.0%
Q3 2019$367,000
-28.3%
16,134
-22.0%
0.00%0.0%
Q2 2019$512,000
+36.2%
20,680
+34.3%
0.00%0.0%
Q1 2019$376,000
+80.8%
15,397
+68.1%
0.00%0.0%
Q4 2018$208,000
-49.8%
9,157
-29.6%
0.00%0.0%
Q3 2018$414,000
+10.1%
13,016
+24.0%
0.00%0.0%
Q2 2018$376,000
+46.9%
10,496
+36.1%
0.00%0.0%
Q1 2018$256,0007,7100.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2018
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders